Tianjin KingYork Group Co. and Innovata HK Limited have gotten together to form a JV, which will be located in Tianjin Economic-Technological Development Area (TEDA). The new company, which will be known as Tianjin Kinnovata Pharmaceutical Company Limited, will produce powder inhalation drugs for asthma and COPD. The JV has been funded with 60 million RMB ($9.6 million) initially. Over the longer term, the partners plan to invest 1.2 billion RMB ($190 million) in the project. More details.... Share this with colleagues: // //